Walmart Agrees to $50 Million Settlement Over Opioid Epidemic Role
Walmart will pay $50 million to settle claims that its pharmacies played a role in the opioid epidemic by filling illegal prescriptions and failing to report suspicious orders to the Drug Enforcement Administration.
Greenville Spartanburg Asheville Anderson, SC, August 29, 2026 — Walmart has agreed to a $50 million settlement to resolve claims concerning its pharmacies’ alleged involvement in the opioid epidemic. The settlement addresses allegations that the retail giant’s pharmacies played a role in the crisis through the handling of opioid prescriptions.
According to the claims, Walmart pharmacies are accused of filling prescriptions that were illegal. Additionally, the company is alleged to have failed in its duty to report suspicious orders of controlled substances to the Drug Enforcement Administration (DEA).
The financial settlement of $50 million is intended to address these claims. Specific details regarding the timeframe of the alleged activities, the exact nature of the illegal prescriptions, or the quantity and nature of the suspicious orders that were not reported were not provided in the summary. Furthermore, information on which specific jurisdictions or entities brought these claims against Walmart was not specified.
The opioid epidemic has been a significant public health crisis, with numerous legal actions filed against various entities, including pharmaceutical manufacturers, distributors, and pharmacies, for their alleged roles in contributing to widespread addiction and overdose deaths. This settlement represents one such resolution involving a major retail pharmacy chain.
The terms of the settlement, including how the funds will be disbursed, were not detailed in the provided summary. The specific individuals or governmental bodies receiving the settlement funds were also not specified. The Drug Enforcement Administration is a federal agency responsible for enforcing the laws and regulations of the United States regarding controlled substances. Reporting suspicious orders is a key component of preventing the diversion of prescription drugs into illicit channels.
Story summarized from the original created by Gray News staff on www.foxcarolina.com, see more information here.
Media gallery
